A Multicenter Study to Assess a Systematic Screening of Occupational Exposures in Lung Cancer Patients.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
13 03 2023
Historique:
received: 24 02 2023
revised: 10 03 2023
accepted: 12 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Occupational lung cancer cases remain largely under-reported and under-compensated worldwide. In order to improve the detection and compensation of work-related lung cancers, we implemented a systematic screening of occupational exposures, combining a validated self-administered questionnaire to assess occupational exposures and a specialized occupational cancer consultation. After a pilot study, the present prospective, open-label, scale-up study aimed to assess this systematic screening of occupational exposures in lung cancer patients in five sites in France by associating university hospitals with cancer centers. Patients with lung cancer were sent a self-administered questionnaire to collect their job history and potential exposure to lung carcinogens. The questionnaire was assessed by a physician to determine if a specialized occupational cancer consultation was required. During the consultation, a physician assessed if the lung cancer was occupation-related and, if it was, delivered a medical certificate to claim for compensation. Patients were offered help from a social worker for the administrative procedure. Over 15 months, 1251 patients received the questionnaire and 462 returned it (37%). Among them, 176 patients (38.1%) were convened to the occupational cancer consultation and 150 patients attended the consultation. An exposure to occupational lung carcinogen was identified in 133 patients and a claim for compensation was judged possible for 90 patients. A medical certificate was delivered to 88 patients and 38 patients received compensation. Our national study demonstrated that a systematic screening of occupational exposures is feasible and will bring a significant contribution to improve the detection of occupational exposures in lung cancer patients.

Identifiants

pubmed: 36981979
pii: ijerph20065068
doi: 10.3390/ijerph20065068
pmc: PMC10049492
pii:
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

J Expo Sci Environ Epidemiol. 2023 Jan;33(1):125-131
pubmed: 34172838
Pneumologie. 2016 Aug;70(8):510-3
pubmed: 27512930
Occup Environ Med. 2018 Aug;75(8):593-603
pubmed: 29769352
Int J Epidemiol. 2012 Jun;41(3):711-21
pubmed: 22467291
Prev Med. 2019 May;122:128-139
pubmed: 31078166
Public Health Rep. 2006 Nov-Dec;121(6):703-9
pubmed: 17278405
Tidsskr Nor Laegeforen. 2014 Oct 28;134(20):1943-7
pubmed: 25350438
J Cancer Surviv. 2023 Apr;17(2):416-424
pubmed: 35469363
Int Arch Occup Environ Health. 2016 Aug;89(6):981-9
pubmed: 27137812
Br J Ind Med. 1991 May;48(5):292-8
pubmed: 2039741
BMC Public Health. 2017 Feb 14;17(1):191
pubmed: 28193266
Bull Cancer. 2013 Jul-Aug;100(7-8):661-70
pubmed: 23831888
Eur Arch Otorhinolaryngol. 2019 Mar;276(3):857-864
pubmed: 30607561
N Engl J Med. 2011 Aug 4;365(5):395-409
pubmed: 21714641
Cochrane Database Syst Rev. 2015 Mar 25;(3):CD010305
pubmed: 25805310
Int J Environ Res Public Health. 2021 May 14;18(10):
pubmed: 34069196
Eur J Public Health. 2015 Aug;25(4):604-9
pubmed: 25624273
J Korean Med Sci. 2014 Nov;29(11):1473-81
pubmed: 25408577
Health Policy. 2020 Sep;124(9):1032-1040
pubmed: 32600665
N Engl J Med. 2020 Feb 6;382(6):503-513
pubmed: 31995683
Br J Cancer. 2012 Jun 19;107 Suppl 1:S56-70
pubmed: 22710680
Sante Publique. 2017 Oct 2;29(4):569-578
pubmed: 29034672
Int Arch Occup Environ Health. 2010 Apr;83(4):381-8
pubmed: 19830449
Occup Environ Med. 2018 Aug;75(8):604-614
pubmed: 29735747
Rev Mal Respir. 2016 Jun;33(6):444-59
pubmed: 26572259
Rev Epidemiol Sante Publique. 2011 Dec;59(6):393-400
pubmed: 22036467
Clin Chest Med. 2020 Dec;41(4):723-737
pubmed: 33153690
Am J Ind Med. 2010 Sep;53(9):922-30
pubmed: 20583130
Rev Prat. 2008 Dec 15;58(19 Suppl):9-16
pubmed: 19253786
Int J Environ Res Public Health. 2019 Dec 30;17(1):
pubmed: 31905913
Occup Med (Lond). 2008 Aug;58(5):373-5
pubmed: 18504259
Int J Hyg Environ Health. 2019 Jan;222(1):22-29
pubmed: 30174219
Int J Environ Res Public Health. 2018 Jan 04;15(1):
pubmed: 29300325
Med Lav. 2019 Aug 26;110(4):278-284
pubmed: 31475689
Rev Mal Respir. 2014 Mar;31(3):221-9
pubmed: 24680113
Lung Cancer. 2019 May;131:23-30
pubmed: 31027694
Bull Cancer. 2017 Jun;104(6):559-564
pubmed: 28477873
Occup Environ Med. 2008 Jun;65(6):392-7
pubmed: 17928383
Int J Environ Res Public Health. 2022 Feb 25;19(5):
pubmed: 35270380
Eur J Public Health. 2018 Aug 1;28(4):707-712
pubmed: 29741657
Chest. 2014 Jun;145(6):1339-1346
pubmed: 24480869
Occup Environ Med. 2008 Jan;65(1):32-7
pubmed: 17728406

Auteurs

Olivia Pérol (O)

Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France.
INSERM U1296 Radiations: Défense, Santé, Environnement, Centre Léon Bérard, 69373 Lyon, France.

Nadège Lepage (N)

CHU Lille, Centre Régional de Pathologies Professionnelles et Environnementales, 59800 Lille, France.
CHU Lille, ULR 4483-IMPECS-IMPact de l'Environnement Chimique sur la Santé Humaine, University of Lille, 59000 Lille, France.

Hugo Noelle (H)

Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France.
Faculté de Médecine, Université Claude Bernard Lyon 1, 69373 Lyon, France.
Service d'Evaluation Economique en Santé, Hospices Civils de Lyon, Pôle de Santé Publique, 69003 Lyon, France.

Pierre Lebailly (P)

INSERM U1086, Unité de Recherche Interdisciplinaire pour la Prévention et le Traitement des Cancers, Université de Caen Normandie, UFR Santé, 14032 Caen, France.
Centre François Baclesse, 14076 Caen, France.

Benoit de Labrusse (B)

Institut du Cancer Sainte Catherine, 84918 Avignon, France.

Bénédicte Clin (B)

INSERM U1086, Unité de Recherche Interdisciplinaire pour la Prévention et le Traitement des Cancers, Université de Caen Normandie, UFR Santé, 14032 Caen, France.
Service de Santé au Travail et Pathologie Professionnelle, CHRU de Caen, 14033 Caen, France.

Mathilde Boulanger (M)

Centre François Baclesse, 14076 Caen, France.

Delphine Praud (D)

Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France.
INSERM U1296 Radiations: Défense, Santé, Environnement, Centre Léon Bérard, 69373 Lyon, France.

Françoise Fournié (F)

Département Interdisciplinaire des Soins de Support du Patient en Oncologie, Service Social, Centre Léon Bérard, 69373 Lyon, France.

Géraud Galvaing (G)

Chirurgie Thoracique, Centre Jean Perrin, 63011 Clermont-Ferrand, France.

Frédéric Dutheil (F)

Université Clermont Auvergne, CNRS, LaPSCo, Service Santé Travail Environnement, CHU Clermont Ferrand, 63011 Clermont-Ferrand, France.

Brigitte Le Meur (B)

Institut du Cancer Sainte Catherine, 84918 Avignon, France.

Daniel Serin (D)

Institut du Cancer Sainte Catherine, 84918 Avignon, France.

Eric Dansin (E)

Département d'Oncologie Médicale, Centre Oscar Lambret, 59000 Lille, France.

Catherine Nisse (C)

CHU Lille, Centre Régional de Pathologies Professionnelles et Environnementales, 59800 Lille, France.
CHU Lille, ULR 4483-IMPECS-IMPact de l'Environnement Chimique sur la Santé Humaine, University of Lille, 59000 Lille, France.

Barbara Charbotel (B)

UMRESTTE (Unité Mixte IFSTTAR/UCBL), Université Lyon 1, 69373 Lyon, France.
Service des Maladies Professionnelles, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France.

Beatrice Fervers (B)

Département Prévention Cancer Environnement, Centre Léon Bérard, 69373 Lyon, France.
INSERM U1296 Radiations: Défense, Santé, Environnement, Centre Léon Bérard, 69373 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH